Propranolol: Clinical Trials

345 trials of Propranolol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

154 completed, 69 unknown, 39 recruiting, 39 terminated. 126 Phase 2, 62 Not applicable, 61 Phase 4, 54 Phase 3, 43 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 2126Completed 47, Terminated 23, Unknown 20, Recruiting 16, Withdrawn 8, Active not recruiting 4, Not yet recruiting 4, Suspended 4
Not applicable62Completed 29, Unknown 18, Recruiting 5, Not yet recruiting 3, Withdrawn 3, Enrolling by invitation 2, Active not recruiting 1, Terminated 1
Phase 461Completed 31, Unknown 14, Recruiting 5, Terminated 5, Not yet recruiting 4, Enrolling by invitation 1, Withdrawn 1
Phase 354Completed 22, Unknown 13, Terminated 9, Recruiting 4, Not yet recruiting 3, Withdrawn 3
Phase 143Completed 19, Terminated 8, Recruiting 6, Unknown 3, Suspended 2, Withdrawn 2, Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1
Early Phase 118Completed 8, Recruiting 5, Unknown 3, Active not recruiting 1, Not yet recruiting 1

Follow Propranolol: new trials by email Literature Review of Propranolol trials Research Report on Propranolol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Women Who Are Victims of Violence: Treatment of PTSD Through Reactivation of Traumatic Memories Using Propranolol
Propranolol, Psychotherapy - Post-Traumatic Stress Disorder, PTSD
Phase 3Not yet recruitingUniversity Hospital, Toulouse702026-12-012026-11-06
Efficacy of Cognitive Behavioral Therapy at Vestibular Migraine
•Group A: Patients will receive Medical treatment only: Beta-blockers (Propranolol) , Calcium channel blockers, Group B: Cognitive Behavioral Therapy (CBT) +Medical treatment - Cognitive Behavioral Therapy to Medical Treatment on Functional Ability of Patients With Vestibular Migraine
Not applicableNot yet recruitingSohag University602026-11-012026-10-07
Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular Cancer
Biospecimen Collection, Cholecalciferol, Computed Tomography - Advanced Hepatocellular Carcinoma, Advanced Melanoma
Phase 2Not yet recruitingUniversity of Southern California462026-11-012026-09-23
Impact of Propranolol on the Prognosis of Patients With Decompensated Cirrhosis and MELD Score > 9
conventional therapy, propranolol - Cirrhosis
Not applicableNot yet recruitingGeneral Hospital of Shenyang Military Region4662026-09-012026-09-15
Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence
Propranolol, 120mg, Placebo - PTSD - Post Traumatic Stress Disorder
Phase 2Not yet recruitingUniversity Hospital, Tours342026-09-012026-03-05
A Study of Propranolol to Treat Kaposi Sarcoma
Propranolol - Kaposi Sarcoma
Phase 2RecruitingAIDS Malignancy Consortium252026-08-312026-10-05
Neoadjuvant Propranolol Plus SOX and Toripalimab for Locally Advanced Gastric/GEJ Adenocarcinoma
propranolol, Toripalimab, Oxaliplatin - Gastric or Gastroesophageal Junction Adenocarcinoma, Propranolol
Phase 1 / Phase 2Not yet recruitingTing Liu492026-08-012026-07-27
Comparison of Propranolol, Flunarizine and Their Combination in Preventing Migraine in Adults in a Tertiary Care Hospital in Bangladesh
Propranolol 80 mg, Flunarizine 10 mg, Propranolol 40 mg + Flunarizine 10mg - Migraine Prophylaxis
Phase 4Not yet recruitingChittagong Medical College1772026-07-012026-06-22
Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)
Galcanezumab, Erenumab 70 mg, Eptinezumab - Migraine Associated Vertigo, Tinnitus
Phase 4Not yet recruitingStanford University1202026-07-012026-06-17
Preventive Role of Melatonin and Propranolol Administration in Pediatric Migraine
Melatonin, Propranolol - Migraine Disorders
Not applicableEnrolling by invitationNishtar Medical University602026-06-102026-08-03
Propranolol Hydrochloride Combined With Toripalimab and Platinum-based Chemotherapy in Resectable Non-Small Cell Lung Cancer
Propranolol Hydrochloride, Toripalimab, Chemotherapy - Resectable Non-Small-Cell Lung Cancer
Phase 1RecruitingSecond Xiangya Hospital of Central South University92026-06-012026-10-21
Efficacy of Propranolol in Traumatic Brain Injury Patients Admitted to the ICU: A Prospective, Randomized, Triple-Blind Study
Propranolol + Placebo - Traumatic Brain Injury (TBI) Patients
Phase 3RecruitingFundació d'investigació Sanitària de les Illes Balears5362026-06-012026-10-27
Propranolol Hydrochloride Combined With Adebrelimab and Platinum-Based Chemotherapy in Small Cell Lung Cancer
Propranolol Hydrochloride, Adebrelimab, Chemotherapy - Small Cell Lung Cancer (SCLC)
Phase 1RecruitingSecond Xiangya Hospital of Central South University182026-05-292026-10-21
Impact of Propranolol Strategies on Myocardial Injury After Breast Cancer Surgery
propranolol, Usual Care - Breast Cancer, Myocardial Injury After Noncardiac Surgery (MINS)
Phase 4Not yet recruitingChang-Ik Yoon1002026-05-262026-05-15
Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma
Biopsy, Biospecimen Collection, Computed Tomography - Soft Tissue Sarcoma
Phase 1WithdrawnRoswell Park Cancer Institute2026-05-152025-08-26
Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study
Iparomlimab/Tuvonralimab, Capecitabine, Oxaliplatin - Colon Cancer (Stage II &Amp; III), Immunotherapy
Phase 2Not yet recruitingSun Yat-sen University452026-04-202026-04-24
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
Testosterone Enanthate, Testosterone Cypionate, Testosterone Propionate - Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes
Not applicableEnrolling by invitationEnhanced Emirates Limited602026-03-122026-05-06
Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism
Propranolol, Placebo - Autism Spectrum Disorder, Challenging Behaviour
Phase 2RecruitingJeremy Veenstra-vanderweele602026-01-302026-09-01
Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC
propranolol, Tislelizumab, gemcitabine - Bladder Urothelial Carcinoma, Lymph Node Metastasis
Phase 1Enrolling by invitationSun Yat-Sen Memorial Hospital of Sun Yat-Sen University122026-01-012026-04-22
Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic Varices
Propranolol, Carvedilol - Rebleeding of Portal Hypertension in Liver Cirrhosis, Propranolol
Phase 4Enrolling by invitationXijing Hospital3502026-01-012026-01-20

Showing 20 of 345. Sign in to see all of them.

Conditions studied

Stress Disorders, Post-Traumatic (26)  ·  Hypertension, Portal (17)  ·  Migraine Disorders (16)  ·  Fibrosis (13)  ·  Brain Injuries, Traumatic (12)  ·  Liver Cirrhosis (12)  ·  Hemangioma (9)  ·  Burns (8)  ·  Esophageal and Gastric Varices (8)  ·  Hemangioma, Capillary (7)  ·  Melanoma (7)  ·  Wounds and Injuries (7)  ·  Cardiovascular Diseases (6)  ·  Cocaine-Related Disorders (6)  ·  Retinopathy of Prematurity (6)

Sponsors

University of Missouri-Columbia (8)  ·  Govind Ballabh Pant Hospital (6)  ·  Taipei Veterans General Hospital, Taiwan (6)  ·  West China Hospital (6)  ·  Douglas Mental Health University Institute (5)  ·  Massachusetts General Hospital (5)  ·  Mayo Clinic (5)  ·  Roswell Park Cancer Institute (5)  ·  The University of Texas Medical Branch, Galveston (5)  ·  University of North Carolina, Chapel Hill (5)  ·  Eli Lilly and Company (4)  ·  Emory University (4)  ·  University Hospital, Toulouse (4)  ·  Weill Medical College of Cornell University (4)  ·  Ain Shams University (3)

Countries

United States (132)  ·  China (30)  ·  Canada (22)  ·  Egypt (17)  ·  France (14)  ·  India (10)  ·  Taiwan (10)  ·  Germany (7)  ·  South Korea (7)  ·  Brazil (6)  ·  Israel (6)  ·  Spain (6)  ·  Denmark (5)  ·  Italy (5)  ·  Netherlands (5)

Top investigators

David N Herndon, MD (4)  ·  Shiv K Sarin, MD, DM (4)  ·  Brian J Lipworth, MD (3)  ·  David Q Beversdorf, MD (3)  ·  Ming-Chih Hou, MD (3)  ·  Alain Brunet, Ph.D. (2)  ·  James D. Carlson,, Pharm.D, (2)  ·  Jason A Oliver, PhD (2)  ·  Oded Zmora, MD (2)  ·  Parag Goyal, MD (2)  ·  Sean van Diepen, MD, MSc (2)  ·  A. Eden Evins, MD, MPH (1)

Results publications

PMID 42088573, PMID 11914403, PMID 12807523, PMID 22606232, PMID 33089892, PMID 38767196, PMID 8984084, PMID 15316798, PMID 15583741, PMID 15890495, PMID 15911704, PMID 15978266, PMID 16697124, PMID 18550886, PMID 18791359, PMID 19240154, PMID 19687359, PMID 19734776, PMID 19840322, PMID 19903189, PMID 20117846, PMID 20395554, PMID 20547163, PMID 20551457, PMID 20583214, PMID 20644039, PMID 20701787, PMID 20732454, PMID 20739853, PMID 20797926, PMID 20880898, PMID 20881067, PMID 20936416, PMID 21145834, PMID 21266211, PMID 21789167, PMID 21953407, PMID 22070357, PMID 22077869, PMID 22365565, PMID 22401315, PMID 22456397, PMID 22463890, PMID 22706835, PMID 22895351, PMID 22962431, PMID 23013802, PMID 23031335, PMID 23150682, PMID 23303450

NIH funding

2008 (2), 2017 (2), 2023 (2), 2025 (2), P50GM060338 (2), 1RC1AA019019-01 (1), 2005 (1), 2015 (1), 2018 (1), 5UL1TR000445-07 (1), K01HL096434 (1), K08CA279766 (1), K20DA000238 (1), K76AG064428 (1), P30CA012197 (1)